Sign Up Today and Learn More About Ingenza Stock
Invest in or calculate the value of your shares in Ingenza or other pre-IPO companies through EquityZen's platform.
About Ingenza Stock
Founded
2002
Total Funding
50K
Industries
Science and Engineering, Health Care, Biotechnology
Ingenza was founded in 2002, a spin-out company from the University of Edinburgh that was based on the modification and commercialisation of microbial production technologies aimed at improving yields of unnatural amino acids and amines. Since its inception, Ingenza has remained strongly committed to the continuous development and integration of innovative technologies in its core competencies of molecular biology, gene expression, directed evolution, fermentation and process development. Ingenza is a world leader in the application of industrial biotechnology and synthetic biology, providing efficient, scalable bioprocesses for the manufacture of chemicals, biologics, pharmaceuticals and biofuels, from sustainable sources.
Ingenza Press Mentions
Stay in the know about the latest news on Ingenza
The Scottish tech ecosystem is showing significant momentum
insider • Apr 04, 2025
Ingenza partners with HydRegen to advance sustainable biomanufacturing
news-medical • Jan 10, 2025
Endotoxin-free Production of Recombinant Subunit Vaccine Components
patents • Dec 02, 2024
Dog-friendly cafe and luxury skincare firm among 26 Scottish SMEs sharing ÂŁ10m in state funding
scotsman • Nov 26, 2024
Investment Fund for Scotland surpasses ÂŁ10 million in its first year
insider • Nov 25, 2024
Ingenza Management
Leadership team at Ingenza
Managing Director
Ian Fotheringham
Co-Founder and Chief Executive Officer
Sinil Srivastava
Join now and verify your accreditation status to gain access to:
- Ingenza Current Valuation
- Ingenza Stock Price
- Ingenza Management
- Available deals in Ingenza and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ingenza Cap Table and Funding History by Share Class and Liquidity Preferences
- Ingenza Revenue and Financials
- Ingenza Highlights
- Ingenza Business Model
- Ingenza Risk Factors
- Ingenza Research Report from SACRA Research
Trading Ingenza Stock
How to invest in Ingenza stock?
Accredited investors can buy pre-IPO stock in companies like Ingenza through EquityZen funds. These investments are made available by existing Ingenza shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ingenza stock?
Shareholders can sell their Ingenza stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
